How Does Dabigatran Compare with Warfarin for Secondary Stroke Prevention? Subgroup Analysis of the RE-LY Study

Article Information

DOI 
http://dx.doi.org/10.1177/155989771001005
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2010 MD Conference Express

Author Information

  1. Heather Q. Sinclair
  1. Hans-Christophe Diener, MD, PhD
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
May 2015200
Jun 2015600
Aug 2015211
Sep 2015400
Oct 2015133
Nov 2015100
Total2244

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
How Does Dabigatran Compare with Warfarin for Secondary Stroke Prevention? Subgroup Analysis of the RE-LY Study
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Arrhythmias
Neurology Clinical Trials
Ischemia
Cerebrovascular Disease
Episodic & Paroxysmal Disorders